Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease

Variable Healthy Controls
N = 16
T2DM
N = 31
P value
Age, y 51 ± 9 55 ± 9 0.162
BMI, kg/m2 25.8 ± 4.2 28.7 ± 5.6 0.083
Male, % 53 58 0.739
Diabetes duration, y 7[IQR:1–8]  
Systolic blood pressure, mmHg 121 ± 13 125 ± 11 0.366
Diastolic blood pressure, mmHg 71 ± 9 77 ± 8 0.048
Resting heart rate, bpm 58 ± 10 69 ± 8 <0.001
Plasma fasting glucose 4.8 ± 0.5 9.1 ± 3.2 <0.001
Plasma triglycerides, mmol/L 1.25 ± 0.68 1.47 ± 0.71 0.391
Total cholesterol, mmol/L 3.58 ± 0.93 1.99 ± 0.63 <0.001
HDL, mmol/L 1.32 ± 0.37 1.22 ± 0.36 0.442
LDL, mmol/L 2.86 ± 0.56 1.99 ± 0.63 <0.001
Hematocrit, % 41 ± 4 42 ± 3 0.501
Medications, n (%)
 Metformin 30 (97)  
 Sulphonylurea 21 (68)  
 Aspirin 11 (35)  
 Statin 24 (77)  
 ACE-I 21 (68)  
  1. Values are mean ± standard deviations or percentages. T2DM indicates type 2 diabetes mellitus; BMI, body mass index; y, years; bpm, beats per minute; HDL, high density lipoprotein; LDL, low density lipoprotein; ACE-I angiotensin-converting enzyme inhibitors